Dennis Henner - Insider Trading Tracker

TetraLogic Pharmaceuticals Corporation

US ˙ OTCPK

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Dennis Henner. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Veja os Insiders com Maior Classificação

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Dennis Henner reportou posses ou negociações nas seguintes empresas:

Ativo	Título	Últimas Posições Reportadas
US:IMGO / Imago BioSciences Inc	Director	0
US:FTSV / Forty Seven, Inc.	Director	0
US:ETTX / Entasis Therapeutics Holdings Inc	10% Owner	0
US:HAIR / Restoration Robotics, Inc.	10% Owner	0
US:RDUS / Radius Recycling, Inc.		2,459,804
US:TLOG / TetraLogic Pharmaceuticals Corporation	10% Owner	2,214,523
US:SIEN / Sientra, Inc.	10% Owner	5,461,530
	10% Owner	2,237,377
US:OPHT / Ophthotech Corp	10% Owner	0
US:AERI / Aerie Pharmaceuticals Inc	Director, 10% Owner	0
US:GMED / Globus Medical, Inc.		0
US:KBIO / KaloBios Pharmaceuticals, Inc.	Director, 10% Owner	15,000
US:SOMX / Somaxon Pharmaceuticals, Inc.	10% Owner	1,275,886
	10% Owner	3
US:ZGNX / Zogenix Inc	10% Owner	9,482,439
US:AVNR / Avanir Pharmaceuticals Inc	10% Owner	12

Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Dennis Henner. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas TLOG / TetraLogic Pharmaceuticals Corporation - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em TLOG / TetraLogic Pharmaceuticals Corporation. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação	Ticker	Insider	Ações Reportadas	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custos	Dias para Máx	Preço em Máx	Lucro Máx ($)	Retorno Máx (%)
2013-12-17	TLOG	Clarus Lifesciences II, L.P.	1,425,063	7.0000	1,425,063	7.0000	9,975,441	31	12.25	7,481,581	75.00

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

Vendas Internas TLOG / TetraLogic Pharmaceuticals Corporation - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em TLOG / TetraLogic Pharmaceuticals Corporation. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas Preço
Reportado Ações
Ajustadas Preço
Ajustado Base de Custos Dias para
Mín Preço em
Mín Máxima Perda
Evitada ($) Máxima Perda
Evitada (%)

2016-02-09 TLOG Clarus Lifesciences II, L.P. 230,507 0.1600 230,507 0.1600 36,881 317 0.0301 -29,943 -81.19

2016-02-08 TLOG Clarus Lifesciences II, L.P. 103,123 0.1900 103,123 0.1900 19,593

2016-02-05 TLOG Clarus Lifesciences II, L.P. 832,881 0.2000 832,881 0.2000 166,576

2016-02-04 TLOG Clarus Lifesciences II, L.P. 500,026 0.1400 500,026 0.1400 70,004

2016-02-03 TLOG Clarus Lifesciences II, L.P. 82,583 0.1500 82,583 0.1500 12,387

2016-02-02 TLOG Clarus Lifesciences II, L.P. 176,306 0.1700 176,306 0.1700 29,972

2016-02-01 TLOG Clarus Lifesciences II, L.P. 140,000 0.2000 140,000 0.2000 28,000

2016-01-29 TLOG Clarus Lifesciences II, L.P. 52,826 0.2600 52,826 0.2600 13,735

2016-01-28 TLOG Clarus Lifesciences II, L.P. 32,521 0.2600 32,521 0.2600 8,455

2016-01-27 TLOG Clarus Lifesciences II, L.P. 209,984 0.2700 209,984 0.2700 56,696

2016-01-26 TLOG Clarus Lifesciences II, L.P. 69,425 0.3000 69,425 0.3000 20,828

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Dennis Henner conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual Preço
da Ação Valor
da Transação Valor
Restante

2023-01-11 2023-01-11 4 IMGO Imago BioSciences, Inc.
Common Stock U - Other -26,095 0 -100.00 36.00 -939,420

2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Stock Option (right to buy) D - Sale to Issuer -10,322 0 -100.00

2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Stock Option (right to buy) D - Sale to Issuer -20,645 0 -100.00

2019-06-14 2019-06-12 4 FTSV Forty Seven, Inc.
Stock Option (right to buy) A - Award 10,322 10,322

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche B Convertible Preferred Stock C - Conversion -8,552,024 0 -100.00

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche A Convertible Preferred Stock C - Conversion -6,702,213 0 -100.00

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B Convertible Preferred Stock C - Conversion -7,500,000 0 -100.00

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock P - Purchase 453,395 1,623,405 38.75 15.00 6,800,925 24,351,075

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock C - Conversion 412,583 1,170,010 54.47

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock C - Conversion 323,341 685,170 89.36

2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock C - Conversion 361,829 361,829

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series B Preferred Stock C - Conversion -1,922,682 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-2 Preferred Stock C - Conversion -755,780 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-1 Preferred Stock C - Conversion -938,489 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock P - Purchase 200,000 3,816,951 5.53 16.00 3,200,000 61,071,216

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 1,922,682 3,616,951 113.48

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 755,780 1,694,269 80.53

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 938,489 938,489

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series B Preferred Stock C - Conversion -1,922,682 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-2 Preferred Stock C - Conversion -755,780 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-1 Preferred Stock C - Conversion -938,489 0 -100.00

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock P - Purchase 200,000 3,816,951 5.53 16.00 3,200,000 61,071,216

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 1,922,682 3,616,951 113.48

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 755,780 1,694,269 80.53

2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock C - Conversion 938,489 938,489

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Series C Preferred Stock C - Conversion -3,389,105 0 -100.00

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Convertible Promissory Note C - Conversion 0

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock C - Conversion 180,881 3,569,986 5.34 7.00 1,266,167 24,989,902

2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock C - Conversion 3,389,105 3,389,105

2017-10-13 2017-10-11 4 HAIR Restoration Robotics Inc
Convertible Promissory Note J - Other 1,259,269.79

2016-09-29 2016-09-27 4 RDUS Radius Health, Inc.
Common Stock J - Other -1,229,902 2,459,804 -33.33

2016-02-10 2016-02-09 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -230,507 2,214,523 -9.43 0.16 -36,881 354,324

2016-02-10 2016-02-08 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -103,123 2,445,030 -4.05 0.19 -19,593 464,556

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-09 3 SIEN Sientra, Inc.
Common Stock 5,461,530

2016-02-05 2016-02-05 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -832,881 2,548,153 -24.63 0.20 -166,576 509,631

2016-02-05 2016-02-04 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -500,026 3,381,034 -12.88 0.14 -70,004 473,345

2016-02-05 2016-02-03 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -82,583 3,881,060 -2.08 0.15 -12,387 582,159

2016-02-02 2016-02-02 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -176,306 3,963,643 -4.26 0.17 -29,972 673,819

2016-02-02 2016-02-01 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -140,000 4,139,949 -3.27 0.20 -28,000 827,990

2016-02-02 2016-01-29 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -52,826 4,279,949 -1.22 0.26 -13,735 1,112,787

2016-01-28 2016-01-28 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -32,521 4,332,775 -0.74 0.26 -8,455 1,126,522

2016-01-28 2016-01-27 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -209,984 4,365,296 -4.59 0.27 -56,696 1,178,630

2016-01-28 2016-01-26 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock S - Sale -69,425 4,575,280 -1.49 0.30 -20,828 1,372,584

2015-06-17 2015-06-16 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -39,701 2,237,377 -1.74 14.30 -567,724 31,994,491

2015-06-17 2015-06-15 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -1,529 2,277,078 -0.07 14.27 -21,819 32,493,903

2015-06-12 2015-06-12 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -6,430 2,278,607 -0.28 14.25 -91,628 32,470,150

2015-06-12 2015-06-11 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -25,168 2,285,037 -1.09 14.27 -359,147 32,607,478

2015-06-10 2015-06-10 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -8,987 2,310,205 -0.39 14.32 -128,694 33,082,136

2015-06-10 2015-06-09 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -13,000 2,319,192 -0.56 14.26 -185,380 33,071,678

2015-06-10 2015-06-08 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -2,662 2,332,192 -0.11 14.25 -37,934 33,233,736

2015-06-03 2015-06-03 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -10,450 2,334,854 -0.45 14.32 -149,644 33,435,109

2015-06-03 2015-06-02 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -11,014 2,345,304 -0.47 14.25 -156,950 33,420,582

2015-06-03 2015-06-01 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -15,010 2,356,318 -0.63 14.29 -214,493 33,671,784

2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock J - Other -1,554,744 0 -100.00

2015-03-24 2015-03-23 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -26,300 2,371,328 -1.10 14.44 -379,772 34,241,976

2015-03-24 2015-03-20 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -27,115 2,397,628 -1.12 14.53 -393,981 34,837,535

2015-03-19 2015-03-19 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -50,012 2,424,743 -2.02 14.61 -730,675 35,425,495

2015-03-19 2015-03-18 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -25,000 2,474,755 -1.00 14.68 -367,000 36,329,403

2015-03-19 2015-03-17 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares S - Sale -79,307 2,499,755 -3.08 14.67 -1,163,434 36,671,406

2015-01-30 2015-01-28 4 AERI AERIE PHARMACEUTICALS INC
Common Stock J - Other -3,139,447 0 -100.00

2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock Warrant C - Conversion 184,812 0 -100.00

2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Series B Preferred Warrant C - Conversion -184,812 0 -100.00

2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock P - Purchase 321,000 3,468,494 10.20 10.00 3,210,000 34,684,940

2015-01-12 2015-01-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -175,000 3,324,259 -5.00 31.11 -5,444,250 103,417,697

2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -10,200 3,499,259 -0.29 31.11 -317,322 108,861,947

2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -13,420 3,509,459 -0.38 30.67 -411,591 107,635,108

2014-12-30 2014-12-29 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -6,214 3,522,879 -0.18 30.03 -186,606 105,792,056

2014-12-30 2014-12-26 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -74,510 3,529,093 -2.07 30.05 -2,239,026 106,049,245

2014-12-24 2014-12-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -263 3,603,603 -0.01 30.00 -7,890 108,108,090

2014-12-24 2014-12-22 4 AERI AERIE PHARMACEUTICALS INC
Common Stock S - Sale -49,441 3,603,866 -1.35 30.36 -1,501,029 109,413,372

2014-06-16 2014-06-11 4 AERI AERIE PHARMACEUTICALS INC
Option (right to buy) A - Award 13,500 13,500

2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock S - Sale -500 4,500 -10.00 44.32 -22,160 199,440

2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock S - Sale -29,217 2,843,564 -1.02 44.53 -1,301,074 126,627,886

2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock S - Sale -200 2,872,781 -0.01 46.80 -9,360 134,446,151

2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock S - Sale -36,880 2,872,981 -1.27 45.90 -1,692,630 131,857,187

2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock S - Sale -79,824 2,909,861 -2.67 44.66 -3,564,988 129,956,138

2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock S - Sale -39,362 2,989,685 -1.30 46.78 -1,841,500 139,868,526

2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock S - Sale -25,697 3,029,047 -0.84 46.02 -1,182,463 139,383,415

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series B Convertible Preferred C - Conversion -91,175 0 -100.00

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-3 Convertible Preferred Stock C - Conversion -53,331 0 -100.00

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-2 Convertible Preferred Stock C - Conversion -217,873 0 -100.00

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-1 Convertible Preferred Stock C - Conversion -269,724 0 -100.00

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock J - Other 694,449 3,689,706 23.18

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock C - Conversion 399,891 2,995,257 15.41

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock C - Conversion 255,881 2,595,366 10.94

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock C - Conversion 1,045,351 2,339,485 80.78

2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock C - Conversion 1,294,134 1,294,134

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Warrants X - Other -23,282 0 -100.00 6.40 -149,056

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Convertible Notes C - Conversion -853,416 0 -100.00

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Series C Convertible Preferred Stock C - Conversion -2,342,944 0 -100.00

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock X - Other 23,282 4,644,705 0.50 6.40 149,056 29,736,330

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock C - Conversion 853,416 4,621,423 22.65 7.00 5,973,912 32,349,961

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock C - Conversion 2,342,944 3,768,007 164.41

2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock P - Purchase 1,425,063 1,425,063 7.00 9,975,441 9,975,441

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series G Preferred Ordinary Shares C - Conversion -203,439 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series F Preferred Ordinary Shares C - Conversion -553,859 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series E Preferred Ordinary Shares C - Conversion -1,239,308 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion -582,456 0 -100.00

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 203,439 2,579,062 8.56

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 553,859 2,375,623 30.40

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 1,239,308 1,821,764 212.77

2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares C - Conversion 582,456 582,456

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Convertible Notes C - Conversion -420,222 0 -100.00

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Warrants C - Conversion -184,812 0 -100.00

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Convertible Preferred Stock C - Conversion -2,727,272 0 -100.00

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock P - Purchase 321,000 3,653,306 9.63 10.00 3,210,000 36,533,060

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock C - Conversion 184,812 3,332,306 5.87 0.05 9,241 166,615

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock C - Conversion 420,222 3,147,494 15.41

2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock C - Conversion 2,727,272 2,727,272

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series C Preferred Stock C - Conversion -186,027 0 -100.00

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series B Preferred Stock C - Conversion -2,542,373 0 -100.00

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock C - Conversion 186,027 2,728,390 7.32

2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock C - Conversion 2,542,373 2,542,373

2013-09-04 2013-09-03 4 GMED GLOBUS MEDICAL INC
Class A Common Stock J - Other -7,244,201 0 -100.00

2013-05-03 2013-05-01 4 KBIO KALOBIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) A - Award 15,000 15,000

2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Common Stock Warrant P - Purchase 227,939 227,939 6.14 1,400,001 1,400,001

2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Series B Convertible Preferred Stock P - Purchase 91,175 91,175 61.42 5,599,968 5,599,968

2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series D Preferred Stock C - Conversion -275,539 0 -100.00

2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series C Preferred Stock C - Conversion -337,622 0 -100.00

2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series B-2 Preferred Stock C - Conversion -1,949,879 0 -100.00

2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock C - Conversion 313,527 2,632,928 13.52

2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock C - Conversion 369,522 2,319,401 18.95

2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock C - Conversion 1,949,879 1,949,879

2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Series E Preferred Stock C - Conversion -7,444,168 0 -100.00

2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock S - Sale -804,232 7,244,201 -9.99 11.16 -8,975,229 80,845,283

2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock C - Conversion 7,444,168 8,048,433 1,231.94

2012-08-02 3 GMED GLOBUS MEDICAL INC
Class A Common Stock 604,265

2012-07-10 2012-07-09 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -1,624,574 1,275,886 -56.01 0.31 -498,744 391,697

2012-07-10 2012-07-06 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -671,217 2,900,460 -18.79 0.29 -195,324 844,034

2012-07-05 2012-07-03 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -98,210 3,571,677 -2.68 0.29 -28,481 1,035,786

2012-07-05 2012-07-02 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -80,348 3,669,887 -2.14 0.29 -23,301 1,064,267

2012-07-02 2012-06-28 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -19,500 3,750,235 -0.52 0.29 -5,655 1,087,568

2012-06-21 2012-06-19 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -12,000 3,759,735 -0.32 0.29 -3,480 1,090,323

2012-06-19 2012-06-15 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -1,450 3,781,735 -0.04 0.29 -420 1,096,703

2012-06-07 2012-06-06 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -8,400 3,783,185 -0.22 0.29 -2,436 1,097,124

2012-06-07 2012-06-05 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -29,555 3,791,585 -0.77 0.29 -8,571 1,099,560

2012-06-06 2012-06-04 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock J - Other -10,942,468 3 -100.00

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy) X - Other -1,290,922 0 -100.00

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy) X - Other -1,706,426 0 -100.00

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock S - Sale -708,810 10,942,471 -6.08 7.49 -5,311,255 81,994,124

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock S - Sale -608,146 11,651,281 -4.96 7.49 -4,556,960 87,305,379

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock X - Other 1,706,426 12,259,427 16.17 3.11 5,311,251 38,157,467

2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock X - Other 1,290,922 10,553,001 13.94 3.53 4,556,955 37,252,094

2012-06-04 2012-05-31 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -29,850 3,821,140 -0.78 0.30 -8,955 1,146,342

2012-06-04 2012-05-30 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -51,007 3,850,990 -1.31 0.30 -15,302 1,155,297

2012-06-04 2012-05-29 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -15,300 3,901,997 -0.39 0.30 -4,622 1,178,793

2012-06-04 2012-05-25 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -293,015 3,917,297 -6.96 0.30 -87,904 1,175,189

2012-06-04 2012-05-23 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -135,250 4,210,312 -3.11 0.30 -40,629 1,264,778

2012-06-04 2012-05-22 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock S - Sale -287,000 4,345,562 -6.20 0.30 -86,990 1,317,140

2011-09-20 2011-09-16 4 ZGNX ZOGENIX, INC.
Common Stock P - Purchase 3,500,000 9,482,439 58.50 2.00 7,000,000 18,964,878

2010-12-07 2010-12-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock J - Other -6,669,204 12 -100.00

2010-11-10 2010-11-09 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,200,000 6,669,216 -15.25 4.81 -5,773,920 32,089,600

2010-11-10 2010-11-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -44,626 7,869,216 -0.56 5.10 -227,593 40,133,002

2010-11-05 2010-11-05 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -332,572 7,913,842 -4.03 4.80 -1,597,377 38,010,975

2010-11-05 2010-11-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,400,106 8,246,414 -14.51 4.52 -6,332,539 37,297,706

2010-11-02 2010-11-02 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,290,871 9,646,520 -11.80 4.49 -5,800,400 43,345,673

2010-11-02 2010-11-01 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -2,478,142 10,937,391 -18.47 5.36 -13,273,424 58,582,854

2010-11-02 2010-10-29 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -1,424,947 13,415,533 -9.60 5.06 -7,215,647 67,933,576

2010-10-12 2010-10-11 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -311,000 14,840,480 -2.05 3.52 -1,093,445 52,177,644

2010-10-12 2010-10-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -240,838 15,151,480 -1.56 3.47 -836,792 52,643,817

2010-07-15 2010-07-13 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock S - Sale -165,000 15,392,318 -1.06 3.53 -583,143 54,399,530

2008-04-11 3 AVNR AVANIR PHARMACEUTICALS
Class A Common Stock 15,557,318

P

Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo

S

Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo

A

Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)

C

Conversão de derivativo

D

Venda ou transferência de ativos de volta para a empresa

F

Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa

G

Doação de ativos pelo ou para o insider

K

Swaps de capital e transações de hedge similares

M

Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)

V

Uma transação voluntariamente reportada no Formulário 4

J

Outro (acompanhado de uma nota explicativa descrevendo a transação)

Data de Negociação	Ticker	Insider	Ações Reportadas	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custos	Dias para Mín	Preço em Mín	Máxima Perda Evitada ($)	Máxima Perda Evitada (%)
2016-02-09	TLOG	Clarus Lifesciences II, L.P.	230,507	0.1600	230,507	0.1600	36,881	317	0.0301	-29,943	-81.19
2016-02-08	TLOG	Clarus Lifesciences II, L.P.	103,123	0.1900	103,123	0.1900	19,593
2016-02-05	TLOG	Clarus Lifesciences II, L.P.	832,881	0.2000	832,881	0.2000	166,576
2016-02-04	TLOG	Clarus Lifesciences II, L.P.	500,026	0.1400	500,026	0.1400	70,004
2016-02-03	TLOG	Clarus Lifesciences II, L.P.	82,583	0.1500	82,583	0.1500	12,387
2016-02-02	TLOG	Clarus Lifesciences II, L.P.	176,306	0.1700	176,306	0.1700	29,972
2016-02-01	TLOG	Clarus Lifesciences II, L.P.	140,000	0.2000	140,000	0.2000	28,000
2016-01-29	TLOG	Clarus Lifesciences II, L.P.	52,826	0.2600	52,826	0.2600	13,735
2016-01-28	TLOG	Clarus Lifesciences II, L.P.	32,521	0.2600	32,521	0.2600	8,455
2016-01-27	TLOG	Clarus Lifesciences II, L.P.	209,984	0.2700	209,984	0.2700	56,696
2016-01-26	TLOG	Clarus Lifesciences II, L.P.	69,425	0.3000	69,425	0.3000	20,828

Data do Arquivo	Data da Transação	Formulário	Ticker	Ativo	Código	Ações	Ações Restantes	Variação Percentual	Preço da Ação	Valor da Transação	Valor Restante
2023-01-11	2023-01-11	4	IMGO	Imago BioSciences, Inc. Common Stock	U - Other	-26,095	0	-100.00	36.00	-939,420
2020-04-07	2020-04-07	4	FTSV	Forty Seven, Inc. Stock Option (right to buy)	D - Sale to Issuer	-10,322	0	-100.00
2020-04-07	2020-04-07	4	FTSV	Forty Seven, Inc. Stock Option (right to buy)	D - Sale to Issuer	-20,645	0	-100.00
2019-06-14	2019-06-12	4	FTSV	Forty Seven, Inc. Stock Option (right to buy)	A - Award	10,322	10,322
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Series B-1 Tranche B Convertible Preferred Stock	C - Conversion	-8,552,024	0	-100.00
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Series B-1 Tranche A Convertible Preferred Stock	C - Conversion	-6,702,213	0	-100.00
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Series B Convertible Preferred Stock	C - Conversion	-7,500,000	0	-100.00
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	P - Purchase	453,395	1,623,405	38.75	15.00	6,800,925	24,351,075
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	C - Conversion	412,583	1,170,010	54.47
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	C - Conversion	323,341	685,170	89.36
2018-10-02	2018-09-28	4	ETTX	Entasis Therapeutics Holdings Inc. Common Stock	C - Conversion	361,829	361,829
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series B Preferred Stock	C - Conversion	-1,922,682	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series A-2 Preferred Stock	C - Conversion	-755,780	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series A-1 Preferred Stock	C - Conversion	-938,489	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	P - Purchase	200,000	3,816,951	5.53	16.00	3,200,000	61,071,216
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	1,922,682	3,616,951	113.48
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	755,780	1,694,269	80.53
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	938,489	938,489
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series B Preferred Stock	C - Conversion	-1,922,682	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series A-2 Preferred Stock	C - Conversion	-755,780	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Series A-1 Preferred Stock	C - Conversion	-938,489	0	-100.00
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	P - Purchase	200,000	3,816,951	5.53	16.00	3,200,000	61,071,216
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	1,922,682	3,616,951	113.48
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	755,780	1,694,269	80.53
2018-07-02	2018-07-02	4	FTSV	Forty Seven, Inc. Common Stock	C - Conversion	938,489	938,489
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Series C Preferred Stock	C - Conversion	-3,389,105	0	-100.00
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Convertible Promissory Note	C - Conversion		0
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Common Stock	C - Conversion	180,881	3,569,986	5.34	7.00	1,266,167	24,989,902
2017-10-17	2017-10-16	4	HAIR	Restoration Robotics Inc Common Stock	C - Conversion	3,389,105	3,389,105
2017-10-13	2017-10-11	4	HAIR	Restoration Robotics Inc Convertible Promissory Note	J - Other				1,259,269.79
2016-09-29	2016-09-27	4	RDUS	Radius Health, Inc. Common Stock	J - Other	-1,229,902	2,459,804	-33.33
2016-02-10	2016-02-09	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-230,507	2,214,523	-9.43	0.16	-36,881	354,324
2016-02-10	2016-02-08	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-103,123	2,445,030	-4.05	0.19	-19,593	464,556
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-09		3	SIEN	Sientra, Inc. Common Stock			5,461,530
2016-02-05	2016-02-05	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-832,881	2,548,153	-24.63	0.20	-166,576	509,631
2016-02-05	2016-02-04	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-500,026	3,381,034	-12.88	0.14	-70,004	473,345
2016-02-05	2016-02-03	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-82,583	3,881,060	-2.08	0.15	-12,387	582,159
2016-02-02	2016-02-02	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-176,306	3,963,643	-4.26	0.17	-29,972	673,819
2016-02-02	2016-02-01	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-140,000	4,139,949	-3.27	0.20	-28,000	827,990
2016-02-02	2016-01-29	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-52,826	4,279,949	-1.22	0.26	-13,735	1,112,787
2016-01-28	2016-01-28	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-32,521	4,332,775	-0.74	0.26	-8,455	1,126,522
2016-01-28	2016-01-27	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-209,984	4,365,296	-4.59	0.27	-56,696	1,178,630
2016-01-28	2016-01-26	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	S - Sale	-69,425	4,575,280	-1.49	0.30	-20,828	1,372,584
2015-06-17	2015-06-16	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-39,701	2,237,377	-1.74	14.30	-567,724	31,994,491
2015-06-17	2015-06-15	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-1,529	2,277,078	-0.07	14.27	-21,819	32,493,903
2015-06-12	2015-06-12	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-6,430	2,278,607	-0.28	14.25	-91,628	32,470,150
2015-06-12	2015-06-11	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-25,168	2,285,037	-1.09	14.27	-359,147	32,607,478
2015-06-10	2015-06-10	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-8,987	2,310,205	-0.39	14.32	-128,694	33,082,136
2015-06-10	2015-06-09	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-13,000	2,319,192	-0.56	14.26	-185,380	33,071,678
2015-06-10	2015-06-08	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-2,662	2,332,192	-0.11	14.25	-37,934	33,233,736
2015-06-03	2015-06-03	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-10,450	2,334,854	-0.45	14.32	-149,644	33,435,109
2015-06-03	2015-06-02	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-11,014	2,345,304	-0.47	14.25	-156,950	33,420,582
2015-06-03	2015-06-01	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-15,010	2,356,318	-0.63	14.29	-214,493	33,671,784
2015-05-28	2015-05-26	4	OPHT	Ophthotech Corp. Common Stock	J - Other	-1,554,744	0	-100.00
2015-03-24	2015-03-23	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-26,300	2,371,328	-1.10	14.44	-379,772	34,241,976
2015-03-24	2015-03-20	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-27,115	2,397,628	-1.12	14.53	-393,981	34,837,535
2015-03-19	2015-03-19	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-50,012	2,424,743	-2.02	14.61	-730,675	35,425,495
2015-03-19	2015-03-18	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-25,000	2,474,755	-1.00	14.68	-367,000	36,329,403
2015-03-19	2015-03-17	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	S - Sale	-79,307	2,499,755	-3.08	14.67	-1,163,434	36,671,406
2015-01-30	2015-01-28	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	J - Other	-3,139,447	0	-100.00
2015-01-30	2013-10-25	4/A	AERI	AERIE PHARMACEUTICALS INC Common Stock Warrant	C - Conversion	184,812	0	-100.00
2015-01-30	2013-10-25	4/A	AERI	AERIE PHARMACEUTICALS INC Series B Preferred Warrant	C - Conversion	-184,812	0	-100.00
2015-01-30	2013-10-25	4/A	AERI	AERIE PHARMACEUTICALS INC Common Stock	P - Purchase	321,000	3,468,494	10.20	10.00	3,210,000	34,684,940
2015-01-12	2015-01-08	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-175,000	3,324,259	-5.00	31.11	-5,444,250	103,417,697
2015-01-06	2015-01-05	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-10,200	3,499,259	-0.29	31.11	-317,322	108,861,947
2015-01-06	2015-01-05	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-13,420	3,509,459	-0.38	30.67	-411,591	107,635,108
2014-12-30	2014-12-29	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-6,214	3,522,879	-0.18	30.03	-186,606	105,792,056
2014-12-30	2014-12-26	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-74,510	3,529,093	-2.07	30.05	-2,239,026	106,049,245
2014-12-24	2014-12-23	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-263	3,603,603	-0.01	30.00	-7,890	108,108,090
2014-12-24	2014-12-22	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	S - Sale	-49,441	3,603,866	-1.35	30.36	-1,501,029	109,413,372
2014-06-16	2014-06-11	4	AERI	AERIE PHARMACEUTICALS INC Option (right to buy)	A - Award	13,500	13,500
2014-06-11	2014-06-11	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-500	4,500	-10.00	44.32	-22,160	199,440
2014-06-11	2014-06-11	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-29,217	2,843,564	-1.02	44.53	-1,301,074	126,627,886
2014-06-11	2014-06-10	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-200	2,872,781	-0.01	46.80	-9,360	134,446,151
2014-06-11	2014-06-10	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-36,880	2,872,981	-1.27	45.90	-1,692,630	131,857,187
2014-06-11	2014-06-10	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-79,824	2,909,861	-2.67	44.66	-3,564,988	129,956,138
2014-06-11	2014-06-09	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-39,362	2,989,685	-1.30	46.78	-1,841,500	139,868,526
2014-06-11	2014-06-09	4	OPHT	Ophthotech Corp. Common Stock	S - Sale	-25,697	3,029,047	-0.84	46.02	-1,182,463	139,383,415
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series B Convertible Preferred	C - Conversion	-91,175	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-3 Convertible Preferred Stock	C - Conversion	-53,331	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-2 Convertible Preferred Stock	C - Conversion	-217,873	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-1 Convertible Preferred Stock	C - Conversion	-269,724	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	J - Other	694,449	3,689,706	23.18
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion	399,891	2,995,257	15.41
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion	255,881	2,595,366	10.94
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion	1,045,351	2,339,485	80.78
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion	1,294,134	1,294,134
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Warrants	X - Other	-23,282	0	-100.00	6.40	-149,056
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Convertible Notes	C - Conversion	-853,416	0	-100.00
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Series C Convertible Preferred Stock	C - Conversion	-2,342,944	0	-100.00
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	X - Other	23,282	4,644,705	0.50	6.40	149,056	29,736,330
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	C - Conversion	853,416	4,621,423	22.65	7.00	5,973,912	32,349,961
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	C - Conversion	2,342,944	3,768,007	164.41
2013-12-19	2013-12-17	4	TLOG	TETRALOGIC PHARMACEUTICALS CORP Common Stock	P - Purchase	1,425,063	1,425,063		7.00	9,975,441	9,975,441
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Series G Preferred Ordinary Shares	C - Conversion	-203,439	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Series F Preferred Ordinary Shares	C - Conversion	-553,859	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Series E Preferred Ordinary Shares	C - Conversion	-1,239,308	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	-582,456	0	-100.00
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	203,439	2,579,062	8.56
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	553,859	2,375,623	30.40
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	1,239,308	1,821,764	212.77
2013-11-25	2013-11-22	4	OXFD	Oxford Immunotec Global PLC Ordinary Shares	C - Conversion	582,456	582,456
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Convertible Notes	C - Conversion	-420,222	0	-100.00
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Series B Warrants	C - Conversion	-184,812	0	-100.00
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Series B Convertible Preferred Stock	C - Conversion	-2,727,272	0	-100.00
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	P - Purchase	321,000	3,653,306	9.63	10.00	3,210,000	36,533,060
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	C - Conversion	184,812	3,332,306	5.87	0.05	9,241	166,615
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	C - Conversion	420,222	3,147,494	15.41
2013-10-28	2013-10-25	4	AERI	AERIE PHARMACEUTICALS INC Common Stock	C - Conversion	2,727,272	2,727,272
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Series C Preferred Stock	C - Conversion	-186,027	0	-100.00
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Series B Preferred Stock	C - Conversion	-2,542,373	0	-100.00
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Common Stock	C - Conversion	186,027	2,728,390	7.32
2013-10-02	2013-09-30	4	OPHT	Ophthotech Corp. Common Stock	C - Conversion	2,542,373	2,542,373
2013-09-04	2013-09-03	4	GMED	GLOBUS MEDICAL INC Class A Common Stock	J - Other	-7,244,201	0	-100.00
2013-05-03	2013-05-01	4	KBIO	KALOBIOS PHARMACEUTICALS INC Stock Option (Right to Buy)	A - Award	15,000	15,000
2013-04-30	2013-04-23	4	RDUS	Radius Health, Inc. Common Stock Warrant	P - Purchase	227,939	227,939		6.14	1,400,001	1,400,001
2013-04-30	2013-04-23	4	RDUS	Radius Health, Inc. Series B Convertible Preferred Stock	P - Purchase	91,175	91,175		61.42	5,599,968	5,599,968
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Series D Preferred Stock	C - Conversion	-275,539	0	-100.00
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion	-337,622	0	-100.00
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Series B-2 Preferred Stock	C - Conversion	-1,949,879	0	-100.00
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Common Stock	C - Conversion	313,527	2,632,928	13.52
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Common Stock	C - Conversion	369,522	2,319,401	18.95
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Common Stock	C - Conversion	1,949,879	1,949,879
2012-08-10	2012-08-08	4	GMED	GLOBUS MEDICAL INC Series E Preferred Stock	C - Conversion	-7,444,168	0	-100.00
2012-08-10	2012-08-08	4	GMED	GLOBUS MEDICAL INC Class A Common Stock	S - Sale	-804,232	7,244,201	-9.99	11.16	-8,975,229	80,845,283
2012-08-10	2012-08-08	4	GMED	GLOBUS MEDICAL INC Class A Common Stock	C - Conversion	7,444,168	8,048,433	1,231.94
2012-08-02		3	GMED	GLOBUS MEDICAL INC Class A Common Stock			604,265
2012-07-10	2012-07-09	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-1,624,574	1,275,886	-56.01	0.31	-498,744	391,697
2012-07-10	2012-07-06	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-671,217	2,900,460	-18.79	0.29	-195,324	844,034
2012-07-05	2012-07-03	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-98,210	3,571,677	-2.68	0.29	-28,481	1,035,786
2012-07-05	2012-07-02	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-80,348	3,669,887	-2.14	0.29	-23,301	1,064,267
2012-07-02	2012-06-28	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-19,500	3,750,235	-0.52	0.29	-5,655	1,087,568
2012-06-21	2012-06-19	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-12,000	3,759,735	-0.32	0.29	-3,480	1,090,323
2012-06-19	2012-06-15	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-1,450	3,781,735	-0.04	0.29	-420	1,096,703
2012-06-07	2012-06-06	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-8,400	3,783,185	-0.22	0.29	-2,436	1,097,124
2012-06-07	2012-06-05	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-29,555	3,791,585	-0.77	0.29	-8,571	1,099,560
2012-06-06	2012-06-04	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	J - Other	-10,942,468	3	-100.00
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock Warrant (right to buy)	X - Other	-1,290,922	0	-100.00
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock Warrant (right to buy)	X - Other	-1,706,426	0	-100.00
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	S - Sale	-708,810	10,942,471	-6.08	7.49	-5,311,255	81,994,124
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	S - Sale	-608,146	11,651,281	-4.96	7.49	-4,556,960	87,305,379
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	X - Other	1,706,426	12,259,427	16.17	3.11	5,311,251	38,157,467
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	X - Other	1,290,922	10,553,001	13.94	3.53	4,556,955	37,252,094
2012-06-04	2012-05-31	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-29,850	3,821,140	-0.78	0.30	-8,955	1,146,342
2012-06-04	2012-05-30	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-51,007	3,850,990	-1.31	0.30	-15,302	1,155,297
2012-06-04	2012-05-29	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-15,300	3,901,997	-0.39	0.30	-4,622	1,178,793
2012-06-04	2012-05-25	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-293,015	3,917,297	-6.96	0.30	-87,904	1,175,189
2012-06-04	2012-05-23	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-135,250	4,210,312	-3.11	0.30	-40,629	1,264,778
2012-06-04	2012-05-22	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale	-287,000	4,345,562	-6.20	0.30	-86,990	1,317,140
2011-09-20	2011-09-16	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	3,500,000	9,482,439	58.50	2.00	7,000,000	18,964,878
2010-12-07	2010-12-03	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	J - Other	-6,669,204	12	-100.00
2010-11-10	2010-11-09	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,200,000	6,669,216	-15.25	4.81	-5,773,920	32,089,600
2010-11-10	2010-11-08	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-44,626	7,869,216	-0.56	5.10	-227,593	40,133,002
2010-11-05	2010-11-05	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-332,572	7,913,842	-4.03	4.80	-1,597,377	38,010,975
2010-11-05	2010-11-03	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,400,106	8,246,414	-14.51	4.52	-6,332,539	37,297,706
2010-11-02	2010-11-02	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,290,871	9,646,520	-11.80	4.49	-5,800,400	43,345,673
2010-11-02	2010-11-01	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-2,478,142	10,937,391	-18.47	5.36	-13,273,424	58,582,854
2010-11-02	2010-10-29	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-1,424,947	13,415,533	-9.60	5.06	-7,215,647	67,933,576
2010-10-12	2010-10-11	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-311,000	14,840,480	-2.05	3.52	-1,093,445	52,177,644
2010-10-12	2010-10-08	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-240,838	15,151,480	-1.56	3.47	-836,792	52,643,817
2010-07-15	2010-07-13	4	AVNR	AVANIR PHARMACEUTICALS, INC. Common Stock	S - Sale	-165,000	15,392,318	-1.06	3.53	-583,143	54,399,530
2008-04-11		3	AVNR	AVANIR PHARMACEUTICALS Class A Common Stock			15,557,318